Iradimed (IRMD) Non-Current Assets (2013 - 2026)

Iradimed (IRMD) has 14 years of Non-Current Assets data on file, last reported at $28.0 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $28.0 million, up 5.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $114.4 million (up 33.03% YoY), and the FY2025 annual result was $27.6 million, up 19.45% from the prior year.
• Non-Current Assets climbed to $28.0 million in Q1 2026 per IRMD's latest filing, from $27.6 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $29.8 million in Q3 2025 and troughed at $6.9 million in Q1 2022.
• A 5-year average of $18.1 million and a median of $16.2 million in 2023 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2023: Non-Current Assets dropped 1.39% in 2022, then jumped 112.21% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $8.0 million in 2022, then surged by 101.33% to $16.2 million in 2023, then soared by 42.89% to $23.1 million in 2024, then rose by 19.45% to $27.6 million in 2025, then grew by 1.43% to $28.0 million in 2026.
• Business Quant data shows IRMD's Non-Current Assets at $28.0 million in Q1 2026, $27.6 million in Q4 2025, and $29.8 million in Q3 2025.